ライフサイエンスコーパス: pulmonary artery catheter

1 Hemodynamic data were obtained using a pulmonary artery catheter.

2 e metabolic testing period with an oximetric pulmonary artery catheter.

3 jects 2-mL boluses of saline into a standard pulmonary artery catheter.

4 ction were determined via a rapid thermistor pulmonary artery catheter.

5 mplantation with a rapid-response thermistor pulmonary artery catheter.

6 mic variables were obtained with a Swan-Ganz pulmonary artery catheter.

7 Patients were monitored using a pulmonary artery catheter.

8 n pressure was measured simultaneously using pulmonary artery catheter.

9 cardiography was performed simultaneously to pulmonary artery catheter.

10 s were monitored with an arterial line and a pulmonary artery catheter.

11 ous oxygen saturation with parameters from a pulmonary artery catheter.

12 time of admission and before removal of the pulmonary artery catheter.

13 ls evaluating the safety and efficacy of the pulmonary artery catheter.

14 dilution cardiac output measurements using a pulmonary artery catheter.

15 logous information to that gathered from the pulmonary artery catheter.

16 eight patients with HF were monitored with a pulmonary artery catheter.

17 r to have similar accuracy as thermodilution pulmonary artery catheters.

18 ventilated intensive-care-unit patients with pulmonary artery catheters.

19 ted with femoral arterial and thermodilution pulmonary artery catheters.

20 A total of 24 patients had pulmonary artery catheters.

21 elopment of policies for the rational use of pulmonary artery catheters.

22 and interpreting information from the use of pulmonary artery catheters.

23 Women with HF-CS were less likely to receive pulmonary artery catheters (50% versus 55%; P<0.01) and

24 Centers with shock teams used more pulmonary artery catheters (60% vs 49%; adjusted odds ra

25 e care unit length of stay compared with the pulmonary artery catheter algorithm in nonseptic shock b

26 ardiac output was measured simultaneously by pulmonary artery catheter and aortic transpulmonary ther

27 mic and pulmonary effects were assessed with pulmonary artery catheter and electrical impedance tomog

28 obtained immediately after insertion of the pulmonary artery catheter and repeated 4 and 8 hrs later

29 Women with HF-CS had lower use of pulmonary artery catheters and mechanical circulatory su

30 rs) were instrumented with radial artery and pulmonary artery catheters and performed moderate cycle

31 d ventilation (PLV) are often monitored with pulmonary artery catheters and receive positive end-expi

32 uge lumens), the proximal infusion port of a pulmonary artery catheter, and a 9-Fr introducer sheath,

33 venous extracorporeal life support access, a pulmonary artery catheter, and a carotid artery catheter

34 strumented with a carotid artery catheter, a pulmonary artery catheter, and a tracheostomy tube and s

35 The efficacy and safety of the pulmonary artery catheter are under scrutiny because of

36 Pulmonary vascular measures (pulmonary artery catheter), arterial blood (radial arter

37 ue to insertion of a central catheter, not a pulmonary artery catheter; b) continuous monitoring of l

38 onitoring methods, including thermistors for pulmonary artery catheters, bladder catheters, or esopha

39 A modified pulmonary artery catheter capable of continuous monitori

40 After placement of a pulmonary artery catheter, carotid arterial line, Foley

41 PICCs and from 7-Fr, 16-gauge, 18-gauge, and pulmonary artery catheter CICCs, all with continuous pre

42 Despite this, pulmonary artery catheters continue to be used, especial

43 t of a jugular bulb catheter, placement of a pulmonary artery catheter, critical care consultation, t

44 et, and provide appropriate intervention for pulmonary artery catheter data.

45 In vitro, heparin release of the pulmonary artery catheters decreased significantly after

46 lectron microscopic images of heparin-bonded pulmonary artery catheters demonstrate thrombus formatio

47 ongoing programmatic educational efforts; e) pulmonary artery catheter-derived data need to be used w

48 lism undergoing mechanical thrombectomy with pulmonary artery catheter-derived hemodynamic indices ob

49 A treatment protocol for the use of pulmonary artery catheter-derived variables is proposed

50 incorrect interpretation and application of pulmonary artery catheter-derived variables; and f) lack

51 A pulmonary artery catheter designed to measure right vent

52 zed trials have demonstrated that use of the pulmonary artery catheter does not improve outcomes in p

53 ivered into the right atrium via a multiport pulmonary artery catheter during continuous hemodynamic

54 of mechanical ventilation, vasopressors or a pulmonary artery catheter during the ICU stay, and the d

55 patients with ARDS, we measured hemodynamic (pulmonary artery catheter), echocardiographic, and venti

56 uation Study of Congestive Heart Failure and Pulmonary Artery Catheter Effectiveness) trial at hospit

57 s relating to the efficacy and safety of the pulmonary artery catheter, especially consensus document

58 Indwelling arterial and pulmonary artery catheters facilitated monitoring of hem

59 Animals were instrumented with a pulmonary artery catheter, femoral arterial and venous c

60 atheter for blood pressure measurement and a pulmonary artery catheter for bolus thermodilution.

61 tic peptide are reliable alternatives to the pulmonary artery catheter for diagnosing weaning-induced

62 y interpret derived and measured data from a pulmonary artery catheter for optimal care of these diff

63 ery occlusion pressure (<18-20 mm Hg) in the pulmonary artery catheter group for 72 hrs after enrollm

64 study, and there still may be a role for the pulmonary artery catheter in advanced heart failure.

65 A meta-analysis demonstrated that use of the pulmonary artery catheter in critically ill patients had

66 guided by transpulmonary thermodilution vs. pulmonary artery catheter in shock did not affect ventil

67 a 9-Fr introducer sheath, with and without a pulmonary artery catheter in the lumen.

68 rapeutic efficacy of interventions guided by pulmonary artery catheters in a variety of clinical sett

69 ontraindicated (1B); avoiding routine use of pulmonary artery catheters in ALI/ARDS (1A); to decrease

70 to 6.2% (2006-2008; p < 0.001); insertion of pulmonary artery catheters in ICU decreased from 4.2% to

71 Use of pulmonary artery catheters in ICU patients has declined

72 anically ventilated patients with fiberoptic pulmonary artery catheters in place were randomly assign

73 tients were enrolled in Economic Analysis of Pulmonary Artery Catheters in whom 328 had functional me

74 8 common atrial, and 24 right ventricular or pulmonary artery catheters) in 351 PICU patients were st

75 06-2008, ICUs in the top quartile for in-ICU pulmonary artery catheter insertion (3.4-25.0% of patien

76 ing attempted central venous cannulation for pulmonary artery catheter insertion mandates catheter re

77 d t tests and factors associated with in-ICU pulmonary artery catheter insertion using multilevel mix

78 rombus formation on the balloon 24 hrs after pulmonary artery catheter insertion, increasing dramatic

79 raphic studies; number of central venous and pulmonary artery catheter insertions; number of complete

80 Hemodynamic monitoring of patients with a pulmonary artery catheter is controversial because there

81 The future of the pulmonary artery catheter is questioned; physicians must

82 Multiple studies suggest that routine use of pulmonary artery catheters is not beneficial in critical

83 cal situations in heart failure in which the pulmonary artery catheter may be useful, however.

84 Hemodynamic assessment included pulmonary artery catheter measurements, transthoracic ec

85 Transpulmonary thermodilution (vs. pulmonary artery catheter) monitoring was associated wit

86 eline and transpulmonary thermodilution (vs. pulmonary artery catheter) monitoring was associated wit

87 undred thirty-five consecutive patients with pulmonary artery catheters, of whom 35 were excluded bec

88 spiratory arrest, intra-aortic balloon pump, pulmonary artery catheter or pacemaker placement, revasc

89 Current methods use invasive pulmonary artery catheters or two-dimensional (2-D) echo

90 contour cardiac output monitoring system, or pulmonary artery catheter) or manual tympanic recordings

91 (arterial catheter, central venous catheter, pulmonary artery catheter, or peripherally inserted cent

92 ptom improvement and after therapy guided by pulmonary artery catheters (p = 0.034).

93 rgery patients using both the thermodilution pulmonary artery catheter (PAC) and multicomponent nonin

94 The impact of a strategy using pulmonary artery catheter (PAC) guidance on WRF and outc

95 Over the past 30 years the pulmonary artery catheter (PAC) has become a widely used

96 ies have observed an increase in the rate of pulmonary artery catheter (PAC) use in heart failure adm

97 To examine associations of pulmonary artery catheter (PAC) use with in-hospital dea

98 ined whether the preoperative placement of a pulmonary artery catheter (PAC) with optimization of hem

99 effectively by hemodynamic monitoring with a pulmonary artery catheter (PAC).

100 tent pulmonary artery thermodilution using a pulmonary artery catheter (PAC-CO) with regard to accura

101 cular(LV) systolic function (E-function) and pulmonary artery catheter(PAC) assessment of hemodynamic

102 alance between the benefits and the risks of pulmonary-artery catheters (PACs) has not been establish

103 al ICUs (p = 0.057) were more likely to have pulmonary artery catheters placed in ICU.

104 and hospitals in the top quartile for in-ICU pulmonary artery catheter placement (vs the bottom quart

105 Right ventricular function, renal function, pulmonary artery catheter placement, and type and timing

106 ered cardiac arrest, underwent intubation or pulmonary artery catheter placement, or received tempora

107 arriers include a) increased patient risk of pulmonary artery catheter placement; b) ability to measu

108 for drawing blood; contamination shields for pulmonary artery catheters; povidone-iodine ointment app

109 by transducing a peripheral intravenous and pulmonary artery catheter, respectively, after zeroing a

110 modilution cardiac output measurements via a pulmonary artery catheter should not be done during the

111 condary analysis of the Economic Analysis of Pulmonary Artery Catheters study, a long-term observatio

112 lusions were performed with a balloon-tipped pulmonary artery catheter that housed pressure transduce

113 ion Effectiveness trial, the addition of the pulmonary artery catheter to careful clinical assessment

114 s, there is no indication for routine use of pulmonary artery catheters to adjust therapy during hosp

115 2, 95% confidence interval [CI] 1.13, 1.55), pulmonary artery catheter use (RR 1.56, 95% CI 1.30, 1.8

116 Our objective was to assess recent pulmonary artery catheter use across ICUs and identify f

117 For 2006-2008, we compared pulmonary artery catheter use across ICUs.

118 rns of worsened patient outcome secondary to pulmonary artery catheter use and demonstrably inadequat

119 It also offers guidelines on when pulmonary artery catheter use could be considered in pat

120 Total pulmonary artery catheter use decreased from 10.8% of pa

121 Trends in pulmonary artery catheter use from 2001 to 2008 were ass

122 a prospective, randomized clinical trial on pulmonary artery catheter use has been proposed.

123 given high priority for clinical trials were pulmonary artery catheter use in persistent/refractory c

124 variables; and f) lack of proven benefit of pulmonary artery catheter use in the overall management

125 ion, they had higher rates of renal failure, pulmonary artery catheter use, and mechanical circulator

126 Age, systolic blood pressure with shock, pulmonary artery catheter use, pulmonary capillary wedge

127 ith variation in practice patterns regarding pulmonary artery catheter use.

128 recommendations regarding actions to improve pulmonary artery catheter utility and safety.

129 A pulmonary artery catheter was inserted, a magnetic flow

130 e agreement between echocardiography and the pulmonary artery catheter was moderate (Cohen's Kappa, 0

131 A pulmonary artery catheter was placed in 14 patients with

132 A quadrilumen thermodilution pulmonary artery catheter was placed in minipigs via the

133 measured using thermodilution (TDCO) when a pulmonary artery catheter was present.

134 A pulmonary artery catheter was used for 831 patients (8.1

135 C), critically injured patients requiring a pulmonary artery catheter were randomized to a rapid rew

136 Twenty patients with an existing pulmonary artery catheter were studied in a multidiscipl

137 ted with intensive medical therapy guided by pulmonary artery catheter were studied.

138 When only data from patients with pulmonary artery catheters were analyzed and pulmonary a

139 ctal thermometers were calibrated daily, and pulmonary artery catheters were calibrated on removal fr

140 Pulmonary artery catheters were inserted in critically i

141 Pulmonary artery catheters were inserted shortly after a

142 After a median sternotomy, two pulmonary artery catheters were inserted via the jugular

143 Pulmonary artery catheters were placed for hemodynamic m

144 Pulmonary artery catheters were placed in 11 subjects fo

145 Arterial, venous, and pulmonary artery catheters were placed.

146 Intravenous, femoral artery, and pulmonary artery catheters were placed.

147 Pulmonary artery catheters were removed after 24, 48, 72

148 g) was administered to all dogs via the left pulmonary artery catheter, whereas the right lower lobe

149 d systolic function were instrumented with a pulmonary artery catheter within 48 h of admission.

150 The P(PAO) was measured using a pulmonary artery catheter zeroed to midaxillary level.